Compare
Cigna vs Labcorp (CI vs LH)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year Cigna (CI) returned +13.1% and Labcorp (LH) +46.2%; so far this year the figures are +6.7% and +46.1%.
Cigna is the larger company by market value, about 2.6 times the size of Labcorp.
On trailing earnings, CI trades at 12.9 times and LH at 30.1 times.
Revenue grew +6.8% at CI and +6.0% at LH over the last year.
CI yields 2.11%. LH yields 0.79%.
Data as of the latest close. Not investment advice.
Relative performance
| CI | LH | |
|---|---|---|
| Price | $293.59 | $366.57 |
| 1-day | -2.62% | +0.90% |
| YTD | +6.67% | +46.11% |
| 1 year | +13.10% | +46.22% |
| 3 years | -5.11% | +79.74% |
| Market cap | $77.4B | $29.8B |
| P/E | 12.9 | 30.1 |
| P/S | 0.27 | 2.04 |
| P/B | 1.78 | 3.36 |
| Revenue growth | +6.80% | +6.00% |
| EPS growth | +0.30% | +19.60% |
| Gross margin % | 20.7 | 29.0 |
| Net margin % | 2.1 | 6.9 |
| ROE % | 13.8 | 11.3 |
| Debt / equity | 0.72 | 0.66 |
| FCF yield % | 12.2 | 4.3 |
| Dividend yield % | 2.11 | 0.79 |
| Beta | 0.08 | 0.38 |
| RSI (14) | 49.6 | 69.9 |
| Technical rating |